Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chuangling Ye (CLY) is a traditional Chinese herbal medicine formula primarily utilized for the treatment of chronic inflammatory wounds and ulcers, most notably diabetic foot ulcers (DFU) and plasma cell mastitis abscesses. As a multi-component herbal preparation, it contains approximately 61 active compounds that interact with a broad network of molecular targets. Network pharmacology studies have identified key biological targets including EGFR, TP53, CCND1, IL-1B, and PTGS2, suggesting a mechanism of action that involves modulating inflammatory responses and promoting tissue repair. The formula is typically administered topically as a solution for rinsing or via saturated gauze drainage to improve local inflammatory conditions in abscesses, sinuses, or fistulas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chuangling Ye.